Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Zymeworks Inc.

    NASDAQ: ZYME · Real-Time Price · USD
    12.71
    -0.11 (-0.86%)
    At close: Jun 25, 2025, 3:59 PM
    12.71
    0.00%
    After-hours: Jun 25, 2025, 04:20 PM EDT

    Zymeworks Statistics

    Share Statistics

    Zymeworks has 69.68M shares outstanding. The number of shares has increased by -1.6% in one year.

    Shares Outstanding

    n/a
    		 69.68M

    Shares Change (YoY)

    n/a
    		 -1.6%

    Shares Change (QoQ)

    n/a
    		 1.02%

    Owned by Institutions (%)

    n/a
    		 87.65%

    Shares Floating

    n/a
    		 67.74M

    Failed to Deliver (FTD) Shares

    n/a
    		 6

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 7.19M, so 10.32% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 7.19M

    Short % of Shares Out

    n/a
    		 10.32%

    Short % of Float

    n/a
    		 13.39%

    Short Ratio (days to cover)

    n/a
    		 17.31

    Valuation Ratios

    The PE ratio is -9.05 and the forward PE ratio is -10.26. Zymeworks's PEG ratio is 1.56.

    PE Ratio

    n/a
    		 -9.05

    Forward PE

    n/a
    		 -10.26

    PS Ratio

    n/a
    		 14.55

    Forward PS

    n/a
    		 4.3

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 -9.82

    PEG Ratio

    n/a
    		 1.56
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Zymeworks.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.4, with a Debt / Equity ratio of 0.05.

    Current Ratio

    n/a
    		 3.4

    Quick Ratio

    n/a
    		 3.4

    Debt / Equity

    n/a
    		 0.05

    Debt / EBITDA

    n/a
    		 -175.28

    Debt / FCF

    n/a
    		 -163.36

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $255,197.32

    Profits Per Employee

    n/a
    		 $-410,351.17

    Employee Count

    n/a
    		 299

    Asset Turnover

    n/a
    		 0.16

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 6.08M

    Effective Tax Rate

    n/a
    		 -5.22%

    Stock Price Statistics

    The stock price has increased by 51.31% in the last 52 weeks. The beta is 1.18, so Zymeworks's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.18

    52-Week Price Change

    n/a
    		 51.31%

    50-Day Moving Average

    n/a
    		 12.09

    200-Day Moving Average

    n/a
    		 13.13

    Relative Strength Index (RSI)

    n/a
    		 55.72

    Average Volume (20 Days)

    n/a
    		 570,748

    Income Statement

    In the last 12 months, Zymeworks had revenue of 76.3M and earned -122.69M in profits. Earnings per share was -1.62.

    Revenue

    n/a
    		 76.3M

    Gross Profit

    n/a
    		 65.11M

    Operating Income

    n/a
    		 -119.82M

    Net Income

    n/a
    		 -122.69M

    EBITDA

    n/a
    		 -105.42M

    EBIT

    n/a
    		 -119.82M

    Earnings Per Share (EPS)

    n/a
    		 -1.62
    Full Income Statement

    Balance Sheet

    The company has 66.1B in cash and 18.48B in debt, giving a net cash position of 47.63B.

    Cash & Cash Equivalents

    n/a
    		 66.1B

    Total Debt

    n/a
    		 18.48B

    Net Cash

    n/a
    		 47.63B

    Retained Earnings

    n/a
    		 -830.34B

    Total Assets

    n/a
    		 425.52M

    Working Capital

    n/a
    		 241.36M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -110.04M and capital expenditures -3.07M, giving a free cash flow of -113.11M.

    Operating Cash Flow

    n/a
    		 -110.04M

    Capital Expenditures

    n/a
    		 -3.07M

    Free Cash Flow

    n/a
    		 -113.11M

    FCF Per Share

    n/a
    		 -1.49
    Full Cash Flow Statement

    Margins

    Gross margin is 85.33%, with operating and profit margins of -157.03% and -160.8%.

    Gross Margin

    n/a
    		 85.33%

    Operating Margin

    n/a
    		 -157.03%

    Pretax Margin

    n/a
    		 -152.82%

    Profit Margin

    n/a
    		 -160.8%

    EBITDA Margin

    n/a
    		 -138.16%

    EBIT Margin

    n/a
    		 -157.03%

    FCF Margin

    n/a
    		 -148.24%

    Dividends & Yields

    ZYME does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ZYME is $18.5, which is 45.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $18.5

    Price Target Difference

    n/a
    		 45.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 2.04

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist